Last year the NIH also ended a $258 million programme central to the search for an HIV vaccine.

Scientists have long used a powerful gene-editing tool called CRISPR to make precise changes to DNA. But a different version ...

Two doses of hepatitis B virus vaccine with CpG adjuvant may not be sufficient for people with HIV who do not respond to an ...

Good communication between people with HIV and their healthcare providers is central to ensuring consistent and adaptable care, especially when planning for healthy ageing with HIV. “Treating HIV ...

Cytomegalovirus viremia is prevalent among adults with advanced HIV disease and is linked to increased odds of death within 6 months.

A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is ...

A 2024 protocol published in BMJ Open, outlining a planned systematic review to quantify that excess burden worldwide, noted ...

Young people living with HIV in South Africa achieve high viral suppression rates on long-acting injectable antiretroviral therapy, and all who finished the study chose to continue treatment.

COLOMBO, Oct. 14 (Xinhua) -- Sri Lanka plans to introduce a new injectable HIV-prevention drug from the beginning of 2027 as the country seeks to curb a rise in new HIV infections and meet its 2030 ...

A new study from the London School of Economics and Political Science (LSE) and Duke University, published in The Lancet ...

The East African country's HIV progress is running into a stubborn diagnosis gap, as prevalence stands at 7.3% among women and 4.1% among menUganda's HIV prevalence among adults aged 15 years and ...

Michael Kearns, an actor and director who became a prominent voice during the AIDS crisis after publicly announcing his ...